Triasima Portfolio Management inc. Purchases 3,280 Shares of Amgen Inc. $AMGN
Triasima Portfolio Management inc. Purchases 3,280 Shares of Amgen Inc. $AMGN MarketBeat
Covered in this story
What has happened since
- Amgen is up 0.0% since this was published.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Amgen
- BMO Capital Markets: $418 → $415 by Oct 2027 via GuruFocus
- Wells Fargo: $415 → $430 by Oct 2027 · Equal-Weight via GuruFocus
- UBS: $415 → $470 by Oct 2027 · Buy via MarketBeat
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $AMGN yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Amgen →Dalsna Finance is currently tracking 48 stories mentioning Amgen, the earliest published 8 Oct 2026.
Summary aggregated from MarketBeat's public RSS feed. The full reporting belongs to MarketBeat — please read it on their site.